Browse the evidence

Intranasal delivery of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) could overcome the limitations of subcutaneous administration for obesity treatment.

Practitioners should consider intranasal delivery methods for improving patient adherence and reducing side effects.

Low fat intake is associated with a higher risk of all-cause dementia (HR 1.42 (95%CI: 1.11-1.82)).

Practitioners should be cautious about recommending very low fat diets for older adults due to potential dementia risk.

Chronic co-administration of OXT and GLP-1 decreases body weight without changing food intake.

Combining OXT with GLP-1 may be an effective strategy for reducing body weight in obese populations.

Single injection of OXT/GLP-1 additively decreases food intake.

Using OXT in conjunction with GLP-1 may enhance appetite suppression effects.

Allodynia was observed in 4 patients associated with dose escalation of semaglutide.

Clinicians should be aware of the potential for allodynia in patients taking semaglutide.

BI 1820237 treatment was associated with transient nausea and vomiting at higher doses.

Practitioners should monitor for gastrointestinal side effects when prescribing BI 1820237.

Amylin promotes satiation and recruits multiple central nervous system pathways to regulate food intake.

Understanding amylin's role can help in developing obesity treatments.

Small-molecule GLP1RAs regulate both homeostatic and hedonic feeding through parallel neural circuits.

Practitioners can consider the dual impact of small-molecule GLP1RAs on different feeding behaviors.

GLP1RAs suppress the consumption of palatable foods by reducing dopamine release in the nucleus accumbens.

Understanding this mechanism can help in developing strategies to manage palatable food consumption.

Targeted deletion of the receptor in central amygdalar neurons diminishes the anorectic efficacy of GLP1RAs for reward-driven intake.

This finding highlights the importance of specific neural receptors in the effectiveness of weight loss drugs.

Intestinally derived messengers, including gut hormones and microbial metabolites, regulate feeding behavior.

Understanding these signals can help in developing targeted obesity treatments.

GLP-1 receptor agonism may decrease substance use and relapse.

GLP-1 receptor agonists may be beneficial in addiction treatment.

The hamstrings, iliopsoas, adductors, and tibialis anterior produced the largest downward acceleration about the center of mass.

Understanding these muscle contributions can help in designing rehabilitation programs focusing on these muscle groups.

Expectancy may have played a partial role influencing strength-endurance in previous studies.

Understanding the role of expectancy can help practitioners optimize training outcomes.

Tirzepatide dose-dependently reduced voluntary alcohol consumption and prevented binge and relapse-like drinking.

Tirzepatide may help in managing alcohol use disorder by reducing consumption and preventing relapse.

The HIFEM+RF procedure is reported to be safe and effective, with high patient satisfaction and comfort.

Practitioners can expect high patient satisfaction and comfort with the HIFEM+RF procedure.

RIR rating accuracy did not significantly improve over time.

Practitioners should not expect RIR rating accuracy to improve significantly with time alone.

The placebo group experienced a higher percentage of fatigue and higher subjective perception of exertion compared to the maintenance group.

Supplementation with beta-alanine may help reduce perceived exertion and fatigue during repeated sprints.

Food-related information is distributed across functionally distinct brain networks which act as opponent processes involved in guiding food-related behavior.

Understanding the distinct brain networks involved in food-related behavior can inform strategies for dietary interventions.

The inferred healthfulness or artificiality of foods is the greatest factor underlying similarity judgments, most strongly represented within the Prefrontal network.

Recognizing the impact of perceived healthfulness on food choices can aid in dietary planning.

The response to food images in the Prefrontal network is modulated strongly by judgments of the self-control required to resist eating those foods.

Understanding how self-control influences neural responses can help in developing strategies for better dietary choices.

Environmental cues such as chronic cold exposure, exercise, and caloric restriction potentiate adipocyte browning.

Incorporating cold exposure, exercise, and caloric restriction may enhance browning and its benefits.

GLP-1 receptor agonists can induce psychiatric side effects such as increased impulsivity, dysphoria, and aggression.

Physicians should be cautious of potential psychiatric side effects when prescribing GLP-1 RAs.

There may be a relationship between GLP-1 receptor agonists and mood.

Further investigation is warranted to understand the mood-related effects of GLP-1 RAs.